Abiopharma

🔍 Mehta Rajat (Executive)

Company: BIO-RAD LABORATORIES, INC. (BIO BIO.B)

Report Date: 2025-09-05

Detailed Transactions and Holdings:

• Acquired 1,827 shares of Restricted Stock Units (Derivative)
  Date: 2025-09-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,827.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 5,480 shares of Restricted Stock Units (Derivative)
  Date: 2025-09-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,480.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
• F2: On September 5, 2025, the reporting person was granted 1,827 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
• F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.